Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy

TC Pham, VN Nguyen, Y Choi, S Lee, J Yoon - Chemical reviews, 2021 - ACS Publications
This review presents a robust strategy to design photosensitizers (PSs) for various species.
Photodynamic therapy (PDT) is a photochemical-based treatment approach that involves the …

The blood–brain barrier and blood–tumour barrier in brain tumours and metastases

CD Arvanitis, GB Ferraro, RK Jain - Nature Reviews Cancer, 2020 - nature.com
For a blood-borne cancer therapeutic agent to be effective, it must cross the blood vessel
wall to reach cancer cells in adequate quantities, and it must overcome the resistance …

Recent advances in porphyrin-based nanocomposites for effective targeted imaging and therapy

N Rabiee, MT Yaraki, SM Garakani, SM Garakani… - Biomaterials, 2020 - Elsevier
Porphyrins are organic compounds that continue to attract much theoretical interest, and
have been called the “pigments of life”. They have a wide role in photodynamic and …

Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment

N Ghasemi Darestani, AI Gilmanova… - Cell Communication and …, 2023 - Springer
Oncolytic viruses (OVs) infect, multiply, and finally remove tumor cells selectively, causing no
damage to normal cells in the process. Because of their specific features, such as, the ability …

[HTML][HTML] Oxygen in stem cell biology: a critical component of the stem cell niche

A Mohyeldin, T Garzón-Muvdi, A Quiñones-Hinojosa - Cell stem cell, 2010 - cell.com
The defining hallmark of stem cells is their ability to self-renew and maintain multipotency.
This capacity depends on the balance of complex signals in their microenvironment. Low …

Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression

EL Spaeth, JL Dembinski, AK Sasser, K Watson… - PloS one, 2009 - journals.plos.org
Background Tumor associated fibroblasts (TAF), are essential for tumor progression
providing both a functional and structural supportive environment. TAF, known as activated …

Mesenchymal stem cells engineered for cancer therapy

K Shah - Advanced drug delivery reviews, 2012 - Elsevier
Recent pre-clinical and clinical studies have shown that stem cell-based therapies hold
tremendous promise for the treatment of human disease. Mesenchymal stem cells (MSC) …

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

LS Sasportas, R Kasmieh… - Proceedings of the …, 2009 - National Acad Sciences
The poor prognosis of patients with aggressive and invasive cancers combined with toxic
effects and short half-life of currently available treatments necessitate development of more …

Cell-mediated drug delivery

EV Batrakova, HE Gendelman… - Expert opinion on drug …, 2011 - Taylor & Francis
Introduction: Drug targeting to sites of tissue injury, tumor or infection with limited toxicity is
the goal for successful pharmaceutics. Immunocytes (including mononuclear phagocytes …

[HTML][HTML] Clinical applications of mesenchymal stem cells

N Kim, SG Cho - The Korean journal of internal medicine, 2013 - ncbi.nlm.nih.gov
Mesenchymal stem cells (MSCs) are self-renewing, multipotent progenitor cells with
multilineage potential to differentiate into cell types of mesodermal origin, such as …